Erratum: A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3- indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (Journal of Pharmacology and Experimental Therapies (2006) 318 (1248-1256))

E. Dvir; J. E. Friedman; J. Y. Lee; J. Y. Koh; F. Younis; S. Raz; I. Shapiro; A. Hoffman; A. Dahan; G. Rosenberg; I. Angel; A. Kozak; Duvdevani

Erratum: A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3- indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (Journal of Pharmacology and Experimental Therapies (2006) 318 (1248-1256))

E. Dvir, J. E. Friedman, J. Y. Lee, J. Y. Koh, F. Younis, S. Raz, I. Shapiro, A. Hoffman, A. Dahan, G. Rosenberg, I. Angel, A. Kozak, Duvdevani

School of Pharmacy

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1492
Number of pages	1
Journal	Journal of Pharmacology and Experimental Therapeutics
Volume	319
Issue number	3
State	Published - 2006

Cite this

Dvir, E., Friedman, J. E., Lee, J. Y., Koh, J. Y., Younis, F., Raz, S., Shapiro, I., Hoffman, A., Dahan, A., Rosenberg, G., Angel, I., Kozak, A., & Duvdevani (2006). Erratum: A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3- indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (Journal of Pharmacology and Experimental Therapies (2006) 318 (1248-1256)). Journal of Pharmacology and Experimental Therapeutics, 319(3), 1492.

Dvir, E. ; Friedman, J. E. ; Lee, J. Y. et al. / Erratum : A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3- indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (Journal of Pharmacology and Experimental Therapies (2006) 318 (1248-1256)). In: Journal of Pharmacology and Experimental Therapeutics. 2006 ; Vol. 319, No. 3. pp. 1492.

@article{7deb2b3c043049ff94ec0b82d0479c82,

title = "Erratum: A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3- indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (Journal of Pharmacology and Experimental Therapies (2006) 318 (1248-1256))",

author = "E. Dvir and Friedman, {J. E.} and Lee, {J. Y.} and Koh, {J. Y.} and F. Younis and S. Raz and I. Shapiro and A. Hoffman and A. Dahan and G. Rosenberg and I. Angel and A. Kozak and Duvdevani",

year = "2006",

language = "אנגלית",

volume = "319",

pages = "1492",

journal = "Journal of Pharmacology and Experimental Therapeutics",

issn = "0022-3565",

publisher = "American Society for Pharmacology and Experimental Therapeutics",

number = "3",

}

Dvir, E, Friedman, JE, Lee, JY, Koh, JY, Younis, F, Raz, S, Shapiro, I, Hoffman, A, Dahan, A, Rosenberg, G, Angel, I, Kozak, A & Duvdevani 2006, 'Erratum: A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3- indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (Journal of Pharmacology and Experimental Therapies (2006) 318 (1248-1256))', Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 3, pp. 1492.

Erratum: A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3- indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (Journal of Pharmacology and Experimental Therapies (2006) 318 (1248-1256)). / Dvir, E.; Friedman, J. E.; Lee, J. Y. et al.
In: Journal of Pharmacology and Experimental Therapeutics, Vol. 319, No. 3, 2006, p. 1492.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3- indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (Journal of Pharmacology and Experimental Therapies (2006) 318 (1248-1256))

AU - Dvir, E.

AU - Friedman, J. E.

AU - Lee, J. Y.

AU - Koh, J. Y.

AU - Younis, F.

AU - Raz, S.

AU - Shapiro, I.

AU - Hoffman, A.

AU - Dahan, A.

AU - Rosenberg, G.

AU - Angel, I.

AU - Kozak, A.

AU - Duvdevani,

PY - 2006

Y1 - 2006

UR - http://www.scopus.com/inward/record.url?scp=33751169155&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:33751169155

SN - 0022-3565

VL - 319

SP - 1492

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

IS - 3

ER -

Dvir E, Friedman JE, Lee JY, Koh JY, Younis F, Raz S et al. Erratum: A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3- indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (Journal of Pharmacology and Experimental Therapies (2006) 318 (1248-1256)). Journal of Pharmacology and Experimental Therapeutics. 2006;319(3):1492.

Other files and links

Cite this